{"version":"1.0","type":"link","title":"Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic development.","author_name":"Chhan CB 외","author_url":"https://prs-insight.online/author/Chhan%20CB","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/161653","thumbnail_width":1200,"thumbnail_height":630}